Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Global Sleep Apnea Diagnostic System Market – Insights

Sleep apnea diagnostic systems include, polysomnography (PSG) devices, screening devices, and actigraphy monitoring devices. Polysomnography is a sleep test used to diagnose various sleep disorders. The device is used to record brain waves, the oxygen level in blood, heart rate and breathing, as well as eye and leg movements.

The global sleep apnea diagnostic system market is estimated to account for US$ 14,639.7 Mn in terms of value by the end of 2027.

Global Sleep Apnea Diagnostic System Market: Drivers

Increasing prevalence of sleep apnea is a major factor boosting growth of the global sleep apnea diagnostic system market over the forecast period. For instance, according to the study, ‘Estimation of the global prevalence and burden of obstructive sleep apnea: a literature-based analysis’, published in July 2019, 936 million adults aged 30–69 years have mild to severe obstructive sleep apnea and 425 million adults aged 30–69 years have moderate to severe obstructive sleep apnea globally.

Moreover, high incidence of cardiovascular disorder (CVD) is also expected to aid in growth of the market. For instance, according to American Heart Association’s Heart Disease and Stroke Statistics 2018, around 92.1 million adults in the U.S. are suffering from some form of CVD or the after-effects of stroke.

North America region held dominant position in the global sleep apnea diagnostic system market in 2019, accounting for 53.5% share in terms of volume, followed by Asia Pacific.

Figure 1. Global Sleep Apnea Diagnostic System Market Share (%), by Region, 2019

Sleep Apnea Diagnostic System  | Coherent Market Insights

Global Sleep Apnea Diagnostic System Market: Restraints

High cost of in-lab sleep testing is a major factor hampering growth of the global sleep apnea diagnostic system market. The cost of full polysomnography in the U.S. ranges from US$ 3,500 to US$ 5,000. However, the cost of home sleep testing is around US$ 500 to US$ 800.

Moreover, low awareness among the masses about the serious implications of sleep apnea is also expected to hinder growth of the market. Sleep apnea may lead to other diseases such as diabetes and cardiovascular disorders. Majority of the population, especially in developing regions, is not aware about the serious implications of sleep apnea. If sleep disorder is not treated, it can lead to chronic conditions such as heart failure, stroke, high blood pressure, diabetes, and obesity.

Global Sleep Apnea Diagnostic System Market: Opportunities 

Increasing demand and efficacy of home sleep testing (HST) test solutions is expected to offer lucrative growth opportunity for players in the global sleep apnea diagnostic system market. Efficacy of most wearable home care devices available in the market is significantly lesser as compared to in-lab sleep testing devices. Moreover, a significant number of individuals with sleep-related disorders do not adopt in-house analysis due to diagnostic limitations in obstructive sleep apnea. Therefore, integration of advanced technologies resulting in higher efficacy and reliability of these devices offer lucrative growth opportunities for manufacturers.

Moreover, increasing compliance for home care testing by elderly patients is also expected to aid in growth of the market. HST can be beneficial for home-bound, elderly patients, or those with chronic illness, who require specialized care.

Sleep Apnea Diagnostic System  | Coherent Market Insights

Actigraphy Monitoring Devices segment in the global sleep apnea diagnostic system market was valued at US$ 3,107.2 Mn in 2019 and is expected to reach US$ 5,951.2 Mn by 2027 at a CAGR of 8.5% during the forecast period.

Market Trends/Key Takeaways

Sleep testing services providers are shifting from diagnostic testing methods to integrated care services, which involves pre-test evaluation, diagnostic testing, provision of care, follow-up, and long-term care. Growing interest of insurance providers to encourage home sleep testing over in-lab testing is expected to boost growth of the global sleep apnea diagnostic system market.

Academic institutes are analyzing the scope of sleep testing services and devising a comprehensive study tool for students. Home sleep testing and auto-titrating positive airway pressure (APAP) devices are transforming the sleep apnea diagnostic system market and the role of sleep technologist. This has reduced the amount of work related to the process of analyzing, monitoring, and recording physiologic data of patients undergoing testing.

Value Chain Analysis -

Sleep Apnea Diagnostic System  | Coherent Market Insights

Global Sleep Apnea Diagnostic System Market: Competitive Landscape

Major players operating in the global sleep apnea diagnostic system market include, Koninklijke Philips N.V., SOMNOmedics GmbH, Advanced Brain Monitoring, Inc., Braebon Medical Corporation, Becton, Dickinson and Company, Itamar Medical Ltd., FusionHealth, MGC Diagnostics Corporation, Natus Medical Incorporated, SleepMed, Cleveland Medical Devices Inc., BMC Medical Co, Ltd., and ResMed Inc.

Global Sleep Apnea Diagnostic System Market: Key Developments

Major players in the market are focused on adopting partnership and collaboration strategies to expand their product portfolio. For instance, in December 2019, Itamar Medical Ltd. a manufacturer of noninvasive ambulatory diagnostic medical devices for sleep apnea, collaborated with SoClean Inc., a developer of sleep equipment sanitizers, for commercialization and distribution of Itamar Medical’s WatchPAT ONE home sleep apnea test and Digital Health Services.

Major players in the market are also focused on adopting M&A strategies to expand their product portfolio. For instance, in January 2020, FusionHealth, a sleep health company, and Nox Medical, a sleep monitoring and diagnostics company, merged to form Nox Health, a company that will focus on development of solutions for the treatment of the entire range of sleep health issues, including sleep apnea, circadian disorders, insomnia, and restlessness.

Sleep apnea is a breathing disorder where in breathing repeatedly stops and starts. There are three types of sleep apnea; obstructive sleep apnea, central sleep apnea, and complex sleep apnea syndrome. Obstructive sleep apnea is the most common type. Sleep apnea diagnostic systems include, polysomnography (PSG) devices, screening devices, and actigraphy monitoring devices.Increasing prevalence of sleep apnea is a major factor boosting growth of the global sleep apnea diagnostic system market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Sleep Apnea Diagnostic System market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Sleep Apnea Diagnostic System market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Koninklijke Philips N.V., SOMNOmedics GmbH, Advanced Brain Monitoring, Inc., Braebon Medical Corporation, Becton, Dickinson and Company, Itamar Medical Ltd., FusionHealth, MGC Diagnostics Corporation, Natus Medical Incorporated, SleepMed, Cleveland Medical Devices Inc., BMC Medical Co, Ltd., and ResMed Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Sleep Apnea Diagnostic System market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Sleep Apnea Diagnostic System market

Detailed Segmentation:

  • Sleep Apnea Diagnostic System Market, By Product Type:
    • Polysomnography (PSG) Devices
      • Ambulatory PSG Monitoring Devices
      • Clinical PSG Monitoring Devices
    • Sleep Apnea Screening Devices
      • Nasal Flow Sensors
      • Peripheral Capillary Oxygen Saturation (SPO2)
    • Actigraphy Monitoring Devices
  • Sleep Apnea Diagnostic System Market, By End User:
    • Home Care Settings
    • Hospitals
    • Sleep Centers and Clinics
  • Sleep Apnea Diagnostic System Market, By Region:
    • North America
      • By Product Type:
        • Polysomnography (PSG) Devices
          • Ambulatory PSG Monitoring Devices
          • Clinical PSG Monitoring Devices
        • Sleep Apnea Screening Devices
          • Nasal Flow Sensors
          • Peripheral Capillary Oxygen Saturation (SPO2)
        • Actigraphy Monitoring Devices
      • By End User
        • Home Care Settings
        • Hospitals
        • Sleep Centers and Clinics
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Polysomnography (PSG) Devices
          • Ambulatory PSG Monitoring Devices
          • Clinical PSG Monitoring Devices
        • Sleep Apnea Screening Devices
          • Nasal Flow Sensors
          • Peripheral Capillary Oxygen Saturation (SPO2)
        • Actigraphy Monitoring Devices
      • By End User
        • Home Care Settings
        • Hospitals
        • Sleep Centers and Clinics
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Polysomnography (PSG) Devices
          • Ambulatory PSG Monitoring Devices
          • Clinical PSG Monitoring Devices
        • Sleep Apnea Screening Devices
          • Nasal Flow Sensors
          • Peripheral Capillary Oxygen Saturation (SPO2)
        • Actigraphy Monitoring Devices
      • By End User
        • Home Care Settings
        • Hospitals
        • Sleep Centers and Clinics
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Polysomnography (PSG) Devices
          • Ambulatory PSG Monitoring Devices
          • Clinical PSG Monitoring Devices
        • Sleep Apnea Screening Devices
          • Nasal Flow Sensors
          • Peripheral Capillary Oxygen Saturation (SPO2)
        • Actigraphy Monitoring Devices
      • By End User
        • Home Care Settings
        • Hospitals
        • Sleep Centers and Clinics
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Polysomnography (PSG) Devices
          • Ambulatory PSG Monitoring Devices
          • Clinical PSG Monitoring Devices
        • Sleep Apnea Screening Devices
          • Nasal Flow Sensors
          • Peripheral Capillary Oxygen Saturation (SPO2)
        • Actigraphy Monitoring Devices
      • By End User
        • Home Care Settings
        • Hospitals
        • Sleep Centers and Clinics
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Polysomnography (PSG) Devices
          • Ambulatory PSG Monitoring Devices
          • Clinical PSG Monitoring Devices
        • Sleep Apnea Screening Devices
          • Nasal Flow Sensors
          • Peripheral Capillary Oxygen Saturation (SPO2)
        • Actigraphy Monitoring Devices
      • By End User
        • Home Care Settings
        • Hospitals
        • Sleep Centers and Clinics
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Koninklijke Philips N.V. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • SOMNOmedics GmbH
    • Advanced Brain Monitoring, Inc.
    • Braebon Medical Corporation
    • Becton, Dickinson and Company
    • Itamar Medical Ltd.
    • FusionHealth
    • MGC Diagnostics Corporation
    • Natus Medical Incorporated
    • SleepMed
    • Cleveland Medical Devices Inc.
    • BMC Medical Co, Ltd.
    • ResMed Inc.
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippets, By End User
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Global Sleep Apnea Diagnostic System Market, By Product Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Polysomnography (PSG) Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Ambulatory PSG Monitoring Devices
        • Clinical PSG Monitoring Devices
    • Sleep Apnea Screening Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Nasal Flow Sensors
        • Peripheral Capillary Oxygen Saturation (SPO2)
    • Actigraphy Monitoring Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Sleep Apnea Diagnostic System Market, By End User, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Homecare Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Sleep Centers and Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Sleep Apnea Diagnostic System Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Company Profiles
      • Koninklijke Philips N.V.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • SOMNOmedics GmbH
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Advanced Brain Monitoring, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Braebon Medical Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Itamar Medical Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • FusionHealth
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • MGC Diagnostics Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Natus Medical Incorporated
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • SleepMed
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cleveland Medical Devices Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • BMC Medical Co, Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ResMed Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 26 market data tables and 18 figures on “Sleep Apnea Diagnostic System Market - Global forecast to 2027”.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner